Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy

The resistance of melanoma to current treatment modalities represents a major obstacle for durable therapeutic response, and thus, the elucidation of mechanisms of resistance is urgently needed. The crucial functions of Activating Transcription Factor-2 (ATF2) in the development and therapeutic resi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncogene
Main Authors: Lau, Eric, Sedy, John, Sander, Cindy, Shaw, Misa Austin, Feng, Yongmei, Scortegagna, Marzia, Claps, Giuseppina, Robinson, Steven, Cheng, Phil, Srivas, Rohith, Soonthornvacharin, Stephen, Ideker, Trey, Bosenberg, Marcus, Gonzalez, Réné, Robinson, William, Chanda, Sumit, Ware, Carl, Dummer, Reinhard, Hoon, Dave, Kirkwood, John M., Ronai, Ze'ev A
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558399/
https://ncbi.nlm.nih.gov/pubmed/25728676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2015.22
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares